175 related articles for article (PubMed ID: 16888406)
1. Targeting pericytes diminishes neovascularization in orthotopic uveal melanoma in nerve/glial antigen 2 proteoglycan knockout mouse.
Ozerdem U
Ophthalmic Res; 2006; 38(5):251-4. PubMed ID: 16888406
[TBL] [Abstract][Full Text] [Related]
2. Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer.
Ozerdem U
Prostate; 2006 Feb; 66(3):294-304. PubMed ID: 16245280
[TBL] [Abstract][Full Text] [Related]
3. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma.
Clarijs R; Otte-Höller I; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):912-8. PubMed ID: 11923228
[TBL] [Abstract][Full Text] [Related]
4. Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.
Ozerdem U; Stallcup WB
Angiogenesis; 2004; 7(3):269-76. PubMed ID: 15609081
[TBL] [Abstract][Full Text] [Related]
5. Differential responses of spinal axons to transection: influence of the NG2 proteoglycan.
de Castro R; Tajrishi R; Claros J; Stallcup WB
Exp Neurol; 2005 Apr; 192(2):299-309. PubMed ID: 15755547
[TBL] [Abstract][Full Text] [Related]
6. NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function.
You WK; Yotsumoto F; Sakimura K; Adams RH; Stallcup WB
Angiogenesis; 2014 Jan; 17(1):61-76. PubMed ID: 23925489
[TBL] [Abstract][Full Text] [Related]
7. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?
Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S
Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306
[TBL] [Abstract][Full Text] [Related]
8. NG2 Proteoglycan-Dependent Contributions of Pericytes and Macrophages to Brain Tumor Vascularization and Progression.
Stallcup WB; You WK; Kucharova K; Cejudo-Martin P; Yotsumoto F
Microcirculation; 2016 Feb; 23(2):122-33. PubMed ID: 26465118
[TBL] [Abstract][Full Text] [Related]
9. NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
Brand C; Schliemann C; Ring J; Kessler T; Bäumer S; Angenendt L; Mantke V; Ross R; Hintelmann H; Spieker T; Wardelmann E; Mesters RM; Berdel WE; Schwöppe C
Oncotarget; 2016 Feb; 7(6):6774-89. PubMed ID: 26735180
[TBL] [Abstract][Full Text] [Related]
10. Nerve/glial antigen 2 is crucially involved in the revascularization of freely transplanted pancreatic islets.
Nalbach L; Schmitt BM; Becker V; Scheller A; Laschke MW; Menger MD; Ampofo E
Cell Tissue Res; 2019 Nov; 378(2):195-205. PubMed ID: 31131431
[TBL] [Abstract][Full Text] [Related]
11. In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells.
Li Y; Wang J; Rizvi SM; Jager MJ; Conway RM; Billson FA; Allen BJ; Madigan MC
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4365-71. PubMed ID: 16303921
[TBL] [Abstract][Full Text] [Related]
12. The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.
Iivanainen E; Lauttia S; Zhang N; Tvorogov D; Kulmala J; Grenman R; Salven P; Elenius K
Microvasc Res; 2009 Dec; 78(3):278-85. PubMed ID: 19596357
[TBL] [Abstract][Full Text] [Related]
13. Intravitreally Injected HCmel12 Melanoma Cells Serve as a Mouse Model of Tumor Biology of Intraocular Melanoma.
Kilian MM; Loeffler KU; Pfarrer C; Holz FG; Kurts C; Herwig MC
Curr Eye Res; 2016; 41(1):121-8. PubMed ID: 25658144
[TBL] [Abstract][Full Text] [Related]
14. Modeling the behavior of uveal melanoma in the liver.
Folberg R; Leach L; Valyi-Nagy K; Lin AY; Apushkin MA; Ai Z; Barak V; Majumdar D; Pe'er J; Maniotis AJ
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2967-74. PubMed ID: 17591861
[TBL] [Abstract][Full Text] [Related]
15. [Tumor angiogensis in uveal melanoma. Role of vascular endothelial growth factor (VEGF)].
Proniewska-Skretek E; Mariak Z
Klin Oczna; 2004; 106(4-5):682-5. PubMed ID: 15646494
[TBL] [Abstract][Full Text] [Related]
16. The NG2 Proteoglycan in Pericyte Biology.
Stallcup WB
Adv Exp Med Biol; 2018; 1109():5-19. PubMed ID: 30523586
[TBL] [Abstract][Full Text] [Related]
17. Blood vessel maturation in human uveal melanoma: spatial distribution of neovessels and mature vasculature.
Piña Y; Cebulla CM; Murray TG; Alegret A; Dubovy SR; Boutrid H; Feuer W; Mutapcic L; Jockovich ME
Ophthalmic Res; 2009; 41(3):160-9. PubMed ID: 19321938
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of PDGFRβ expression in different cell types after brain injury.
Kyyriäinen J; Ekolle Ndode-Ekane X; Pitkänen A
Glia; 2017 Feb; 65(2):322-341. PubMed ID: 27778377
[TBL] [Abstract][Full Text] [Related]
19. EMAP-II expression is associated with macrophage accumulation in primary uveal melanoma.
Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2003 May; 44(5):1801-6. PubMed ID: 12714608
[TBL] [Abstract][Full Text] [Related]
20. Novel mouse model for primary uveal melanoma: a pilot study.
Süsskind D; Hurst J; Rohrbach JM; Schnichels S
Clin Exp Ophthalmol; 2017 Mar; 45(2):192-200. PubMed ID: 27505446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
